597 related articles for article (PubMed ID: 18436804)
1. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism.
Fuhrman B; Khateeb J; Shiner M; Nitzan O; Karry R; Volkova N; Aviram M
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1361-7. PubMed ID: 18436804
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages.
Shiner M; Fuhrman B; Aviram M
Free Radic Biol Med; 2004 Dec; 37(12):2052-63. PubMed ID: 15544923
[TBL] [Abstract][Full Text] [Related]
3. Urokinase activates macrophage PON2 gene transcription via the PI3K/ROS/MEK/SREBP-2 signalling cascade mediated by the PDGFR-beta.
Fuhrman B; Gantman A; Khateeb J; Volkova N; Horke S; Kiyan J; Dumler I; Aviram M
Cardiovasc Res; 2009 Oct; 84(1):145-54. PubMed ID: 19497963
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase 2 (PON2) decreases high glucose-induced macrophage triglycerides (TG) accumulation, via inhibition of NADPH-oxidase and DGAT1 activity: studies in PON2-deficient mice.
Meilin E; Aviram M; Hayek T
Atherosclerosis; 2010 Feb; 208(2):390-5. PubMed ID: 19748094
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-type plasminogen activator downregulates paraoxonase 1 expression in hepatocytes by stimulating peroxisome proliferator-activated receptor-γ nuclear export.
Khateeb J; Kiyan Y; Aviram M; Tkachuk S; Dumler I; Fuhrman B
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):449-58. PubMed ID: 22155455
[TBL] [Abstract][Full Text] [Related]
6. Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy.
Rosenblat M; Hayek T; Hussein K; Aviram M
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):175-80. PubMed ID: 14592851
[TBL] [Abstract][Full Text] [Related]
7. A biphasic U-shape effect of cellular oxidative stress on the macrophage anti-oxidant paraoxonase 2 (PON2) enzymatic activity.
Shiner M; Fuhrman B; Aviram M
Biochem Biophys Res Commun; 2006 Oct; 349(3):1094-9. PubMed ID: 16970920
[TBL] [Abstract][Full Text] [Related]
8. Pomegranate juice (PJ) consumption antioxidative properties on mouse macrophages, but not PJ beneficial effects on macrophage cholesterol and triglyceride metabolism, are mediated via PJ-induced stimulation of macrophage PON2.
Rosenblat M; Volkova N; Aviram M
Atherosclerosis; 2010 Sep; 212(1):86-92. PubMed ID: 20537330
[TBL] [Abstract][Full Text] [Related]
9. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
[TBL] [Abstract][Full Text] [Related]
10. Cell-induced copper ion-mediated low density lipoprotein oxidation increases during in vivo monocyte-to-macrophage differentiation.
Fuhrman B; Shiner M; Volkova N; Aviram M
Free Radic Biol Med; 2004 Jul; 37(2):259-71. PubMed ID: 15203197
[TBL] [Abstract][Full Text] [Related]
11. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.
Liu SL; Li YH; Shi GY; Tang SH; Jiang SJ; Huang CW; Liu PY; Hong JS; Wu HL
Cardiovasc Res; 2009 Apr; 82(1):161-9. PubMed ID: 19189960
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidylcholine (LPC) attenuates macrophage-mediated oxidation of LDL.
Rosenblat M; Oren R; Aviram M
Biochem Biophys Res Commun; 2006 Jun; 344(4):1271-7. PubMed ID: 16650824
[TBL] [Abstract][Full Text] [Related]
13. Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: a stimulatory role for D-glucose.
Hayek T; Kaplan M; Kerry R; Aviram M
Atherosclerosis; 2007 Dec; 195(2):277-86. PubMed ID: 17258748
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
Rozenberg O; Rosenblat M; Coleman R; Shih DM; Aviram M
Free Radic Biol Med; 2003 Mar; 34(6):774-84. PubMed ID: 12633754
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
[TBL] [Abstract][Full Text] [Related]
16. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress increases the expression of the angiotensin-II receptor type 1 in mouse peritoneal macrophages.
Keidar S; Heinrich R; Kaplan M; Aviram M
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):24-30. PubMed ID: 11984744
[TBL] [Abstract][Full Text] [Related]
18. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
Pass J; Jögi A; Lund IK; Rønø B; Rasch MG; Gårdsvoll H; Lund LR; Ploug M; Rømer J; Danø K; Høyer-Hansen G
Thromb Haemost; 2007 Jun; 97(6):1013-22. PubMed ID: 17549305
[TBL] [Abstract][Full Text] [Related]
19. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
Ohba K; Miyata Y; Kanda S; Koga S; Hayashi T; Kanetake H
J Urol; 2005 Aug; 174(2):461-5. PubMed ID: 16006865
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-type plasminogen activator (uPA) modulates monocyte-to-macrophage differentiation and prevents Ox-LDL-induced macrophage apoptosis.
Paland N; Aharoni S; Fuhrman B
Atherosclerosis; 2013 Nov; 231(1):29-38. PubMed ID: 24125407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
